Incidence of recurrent fungal keratitis after primary keratoplasty and visual outcome and prognosis after intervention for the recurrence
- PMID: 31192926
- PMCID: PMC6587617
- DOI: 10.1097/MD.0000000000015910
Incidence of recurrent fungal keratitis after primary keratoplasty and visual outcome and prognosis after intervention for the recurrence
Abstract
There are no standardized protocols or guidelines for the treatment of recurrent fungal keratitis after therapeutic keratoplasty. This study aimed to investigate the incidence of recurrent fungal keratitis after the primary keratoplasty and the visual outcome and prognosis after intervention for the recurrence.This was a retrospective study. Patients with recurrent fungal keratitis after lamellar keratoplasty (LK) or penetrating keratoplasty (PK) were treated with different antifungal regimens at Shandong Eye Hospital and Qingdao Eye Hospital between Januray 2004 and December 2015. The operative techniques included PK, focal excision, tectonic keratoplasty with a patch graft, lensectomy and vitrectomy, and combined operation. Patients were followed at 1, 2, and 3 months, and then every 6 months after surgery for 2 years. Best corrected visual acuity was assessed and recurrence was recorded. Good prognosis was defined as the presence of visual acuity.Fungal keratitis recurred in 112 of 1448 patients (112/1448, 7.7%) treated initially with PK or LK. The good prognosis rates for different sites of recurrent fungal keratitis were: overall, 93 of 112 (83.0%); recipient bed, 64 of 69 (92.8%); anterior chamber, 14 of 14 (100%); posterior segment, 10 of 16 (62.5%); and atypical, 5 of 13 (38.5%). There was no significant difference in the timing of recurrence between the good and poor prognosis groups (P = .518). Recurrence rates were similar between patients with PK (8.6%) and those with LK (6.0%; P > .05), but the good prognosis rate in patients with post-LK recurrence (96.8%) was higher than that in patients with post-PK recurrence (77.8%, P = .017).Individualized treatment according to recurrent sites of fungal keratitis can achieve a good prognosis in most patients.
Conflict of interest statement
The authors report no conflicts of interest.
Figures


Similar articles
-
Risk factors, clinical features, and outcomes of recurrent fungal keratitis after corneal transplantation.Ophthalmology. 2010 May;117(5):890-6. doi: 10.1016/j.ophtha.2009.10.004. Epub 2010 Jan 15. Ophthalmology. 2010. PMID: 20079930
-
Therapeutic dilemma in fungal keratitis: administration of steroids for immune rejection early after keratoplasty.Graefes Arch Clin Exp Ophthalmol. 2016 Aug;254(8):1585-1589. doi: 10.1007/s00417-016-3412-0. Epub 2016 Jun 24. Graefes Arch Clin Exp Ophthalmol. 2016. PMID: 27342585
-
Treatment of fungal keratitis by penetrating keratoplasty.Br J Ophthalmol. 2001 Sep;85(9):1070-4. doi: 10.1136/bjo.85.9.1070. Br J Ophthalmol. 2001. PMID: 11520759 Free PMC article.
-
Infectious interface keratitis (IIK) following lamellar keratoplasty: A literature review.Ocul Surf. 2019 Oct;17(4):635-643. doi: 10.1016/j.jtos.2019.08.001. Epub 2019 Aug 12. Ocul Surf. 2019. PMID: 31415815
-
[Mycotic keratitis in an eye care hospital in Mexico City].Rev Iberoam Micol. 2010 Jun 30;27(2):57-61. doi: 10.1016/j.riam.2009.09.003. Epub 2010 Mar 24. Rev Iberoam Micol. 2010. PMID: 20346302 Review. Spanish.
Cited by
-
Dectin-1 participates in the immune-inflammatory response to mouse Aspergillus fumigatus keratitis by modulating macrophage polarization.Front Immunol. 2024 Oct 16;15:1431633. doi: 10.3389/fimmu.2024.1431633. eCollection 2024. Front Immunol. 2024. PMID: 39478855 Free PMC article.
-
Improved Topical Ophthalmic Natamycin Suspension for the Treatment of Fungal Keratitis.J Ocul Pharmacol Ther. 2024 Jan-Feb;40(1):67-77. doi: 10.1089/jop.2023.0092. Epub 2023 Dec 20. J Ocul Pharmacol Ther. 2024. PMID: 38117668 Free PMC article.
-
Local application of silver nitrate as an adjuvant treatment before deep lamellar keratoplasty for fungal keratitis poorly responsive to medical treatment.Front Med (Lausanne). 2024 Jan 22;10:1292701. doi: 10.3389/fmed.2023.1292701. eCollection 2023. Front Med (Lausanne). 2024. PMID: 38317754 Free PMC article.
-
Fusarium Keratitis-Review of Current Treatment Possibilities.J Clin Med. 2021 Nov 23;10(23):5468. doi: 10.3390/jcm10235468. J Clin Med. 2021. PMID: 34884170 Free PMC article. Review.
References
-
- Sauer A, Letscher-Bru V, Speeg-Schatz C, et al. In vitro efficacy of antifungal treatment using riboflavin/UV-A (365 nm) combination and amphotericin B. Invest Ophthalmol Vis Sci 2010;51:3950–3. - PubMed
-
- Carrasco MA, Genesoni G. Treatment of severe fungal keratitis with subconjunctival amphotericin B. Cornea 2011;30:608–11. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources